Liaoning Cheng Da Co., Ltd. (SHA: 600739)

Market Cap	18.56B
Revenue (ttm)	11.29B
Net Income (ttm)	346.30M
Shares Out	1.52B
EPS (ttm)	0.23
PE Ratio	53.59
Forward PE	n/a
Dividend	0.10 (0.81%)
Ex-Dividend Date	Aug 9, 2024

Volume	30,090,847
Open	12.40
Previous Close	12.40
Day's Range	12.05 - 12.55
52-Week Range	7.13 - 13.71
Beta	0.85
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 29, 2024

About Liaoning Cheng Da

Liaoning Cheng Da Co., Ltd. engages in supply chain trade, biopharmaceuticals, financial investment, energy development, and other businesses in China and internationally. The company is involved in the import and export of textiles and clothing, as well as trading of bulk commodities, such as coal, steel, and aquatic and agricultural products; and investment in securities, insurance and funds, and other financial service enterprises. It also offers human rabies vaccine and human JE inactivated vaccines, as well as exports its products to Egypt...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1991
• Employees: 3,356
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600739

Financial Performance

In 2023, Liaoning Cheng Da's revenue was 10.78 billion, a decrease of -25.97% compared to the previous year's 14.56 billion. Earnings were 233.08 million, a decrease of -80.95%.